Evolent Health, Inc.

EVHSEC EDGAR

Services-Management Services(DE)CIK: 1628908

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$2.0B	$1.4B	$908.0M	$924.6M	—
Cost of Revenue	$1.5B	$1.0B	$657.6M	—	—
Research and Development Expense	—	—	—	—	$19.8M
Selling, General and Administrative Expense	$358.1M	$269.3M	$219.5M	$210.4M	$236.4M
Operating Expenses	—	—	$299.9M	$231.0M	$996.0M
Operating Income (Loss)	-$71.2M	$3.6M	-$42.4M	-$262.8M	-$308.9M
Interest Expense	—	—	$25.4M	$28.3M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$2.5B	$2.7B	$1.8B	$1.4B	$1.4B
Assets, Current	$607.1M	$683.7M	$478.1M	$524.0M	$547.6M
Cash and Cash Equivalents, at Carrying Value	$104.2M	$192.8M	$188.2M	$266.3M	$319.0M
Accounts Receivable, after Allowance for Credit Loss, Current	$414.7M	$446.7M	$254.7M	$130.6M	$124.1M
Liabilities	$1.4B	$1.4B	$957.9M	$725.8M	$752.1M
Liabilities, Current	$715.5M	$674.2M	$433.4M	$445.5M	$403.3M
Long-term Debt	—	—	—	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$142.6M	-$11.6M	$38.7M	-$16.2M	-$42.6M
Net Cash Provided by (Used in) Investing Activities	-$415.5M	-$259.1M	-$15.8M	$261.1M	-$181.6M
Net Cash Provided by (Used in) Financing Activities	$281.3M	$131.5M	-$29.5M	-$11.9M	-$35.5M
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—
Payments for Repurchase of Common Stock	$0.00	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)